Cytel’s Post

Setting realistic expectations for how payer coverage is likely to build over time is critical for pharma companies. https://ow.ly/UAB250SjbFW In this case study, learn how one small oncology biopharma used MMIT’s coverage uptake analysis for new drugs to prepare for the launch of its therapy. #FDA #Oncology #Biopharma #BiopharmaInsights #MarketAccess

An Exploration of Oncology Development: 2023 in review DOWNLOAD this interactive PDF to see how biopharma is reshaping the future of cancer care, with an interactive (and fun!) focus on novel drugs, key trial outcomes, and regulatory events of the past year. #biotech #pharmaceuticals #oncology #cancermpact https://lnkd.in/gi58WGyf

A post to everyone in the pharmaceutical and biotech industry - particularly those working in the oncology space. #biotechnologyindustry #pharmaceuticalindustry #biotechnology #oncologyresearch #oncology #cancerresearch #beatcancer #dcat2024

On Tuesday 25 June we will host a special webinar tailored for oncology applications. Reserve your spot today: https://lnkd.in/eu__ZVSK Formulators and developers face a significant challenge. During this webinar, we will evaluate stability data of several small molecule drugs for cancer. Degradation and instability in chemotherapeutics can lead to: - Extended development timelines - Regulatory challenges - Compromised product efficacy. This ultimately delays lifesaving treatments for those who need it most - the patients. We will show you how we can optimise oncological drug delivery resulting in long-term formulation stability, extended drug shelf life, and ultimately improved drug performance and efficacy.

The 5th Cytokine-Based Drug Development Summit is almost upon us and we couldn’t be more pleased for our expert Cytokine team to be in attendance! Harvey Dennis, our expert Account Lead, is preparing to set the scene on Day 1 with a review of the cytokine therapeutics landscape and address the important question, Where Are We Now? Access the full presentation details here. 👉 https://ter.li/llav05 As we receive more clinical read-outs from leading IL-2 and IL-12 therapeutic developers, there has never been a better time to join our peers and accelerate your programs into the clinic. #cytokine #cytokines #cytokinedrugdevelopment #research #oncology #drugdevelopment

Read now the latest edition of Pharma insights! In this edition, you'll dive into the complexities of cancer and understand the path forward in oncology drug development! Plus, stay updated with all the information about our upcoming webinar on June 25. Don't miss out! Click here: https://ow.ly/VOCC30sEeVT #CrodaPharma #PharmaInsights #EmpoweringBiologicsDelivery

📣 ICYMI📣 July's Resource Roundup includes: 📖 How to set up your CDMS/EDC to overcome staffing challenges and grow with you 📊 What other small biopharma orgs and CROs think about the latest eClinical trends 🏥 Meeting the regulatory push for Real-Time Oncology Review (RTOR) while executing mid-study changes Learn more here: https://bit.ly/3W2xbVT #EDC #CDMS #Oncology #Biotech #CRO #DataQuality #ClinicalDataManagement #ClinicalTrials

If you are a pioneering #biotech, #medicaldevice, or #diagnostics company, great insights in this month's Medrio Resource Roundup, including: - Thoughts on selecting technology to serve small teams and to extend your cash runway - Insight into the types of #clinicalresearch technologies that other #lifesciences companies are using as they evolve into #earlyphase trials

In a recent podcast, Allucent experts Sugato De, MS (VP, Regulatory Strategy, Head of MedTech) and Alex MacDonald, PhD (VP, Model Informed Drug Development) explored the exciting world of antibody drug conjugates (ADCs) and radionuclide drug conjugates (RDCs), discussing the tremendous growth potential of these targeted oncology therapies, the challenges faced by small and mid-sized biotech companies, and strategies for navigating the complex regulatory landscape. This podcast was hosted by BioPharma Dive and can be accessed here: https://lnkd.in/g8uSZp7X.   #Allucent #BringNewTherapiesToLife #DrugDiscovery #AntibodyDrugConjugates #Radionuclides #Oncology

Read now the latest edition of Pharma insights! In this edition, you'll dive into the complexities of cancer and understand the path forward in oncology drug development! Plus, stay updated with all the information about our upcoming webinar on June 25. Don't miss out! Click here: https://ow.ly/WCcT30sCWYk #CrodaPharma #PharmaInsights #EmpoweringBiologicsDelivery